(Q34186571)

31 July 2017

1 reference

title

Autologous stem cell transplantation for acute lymphocytic leukemia in adults (English)

1 reference

stem cell transplantation

31 July 2017

0 references

1 reference

1 reference

acute lymphocytic leukemia

inferred from title

1 reference

Martin TG

1

1 reference

PubMed ID

11253604

31 July 2017

Linker CA

series ordinal

2

1 reference

31 July 2017

1 February 2001

1 reference

Hematology / Oncology Clinics of North America

31 July 2017

1 reference

31 July 2017

15

1 reference

31 July 2017

1

1 reference

31 July 2017

121-143

1 reference

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Treatment of acute lymphoblastic leukaemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

RECONSTITUTION OF HAEMOPOIETIC SYSTEM WITH AUTOLOGOUS MARROW TAKEN DURING RELAPSE OF ACUTE MYELOBLASTIC LEUKAEMIA AND GROWN IN LONG-TERM CULTURE

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Long-term results of autologous bone marrow transplantation in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

The role of bone marrow transplantation in adult acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Survival in adult leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Autologous Transplantation with CD52 Monoclonal Antibody-Purged Marrow for Acute Lymphoblastic Leukemia: Long-Term Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

A comparative study of combination chemotherapy versus marrow transplant in first remission in adult acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Extramedullary involvement in acute lymphoblastic leukemia and its relation to therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970202-1

7 January 2021

10.1016/S0889-8588(05)70202-1

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11253604